You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

CLONIDINE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Clonidine patents expire, and when can generic versions of Clonidine launch?

Clonidine is a drug marketed by Tris Pharma Inc, Actavis Labs Ut Inc, Aveva, Dr Reddys Labs Sa, Mylan Technologies, Am Regent, Fresenius Kabi Usa, Hikma Farmaceutica, Xgen Pharms, Zydus Pharms, Actavis Elizabeth, Ajanta Pharma Ltd, Amneal Pharms Ny, Chartwell Rx, Endo Operations, Jubilant Generics, Novast Labs, Somerset Theraps Llc, Xiamen Lp Pharm Co, Alembic Pharms Ltd, Am Therap, Aurobindo Pharma Ltd, Chartwell Molecules, Duramed Pharms Barr, Impax Labs, Interpharm, Par Pharm, Prinston Inc, Rising, Sun Pharm Inds Inc, Teva, Unichem, Url Labs, Warner Chilcott, Watson Labs, and Yung Shin Pharm. and is included in sixty-two NDAs.

The generic ingredient in CLONIDINE is chlorthalidone; clonidine hydrochloride. There are twenty-one drug master file entries for this compound. Additional details are available on the chlorthalidone; clonidine hydrochloride profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for CLONIDINE?
  • What are the global sales for CLONIDINE?
  • What is Average Wholesale Price for CLONIDINE?
Drug patent expirations by year for CLONIDINE
Drug Prices for CLONIDINE

See drug prices for CLONIDINE

Drug Sales Revenue Trends for CLONIDINE

See drug sales revenues for CLONIDINE

Recent Clinical Trials for CLONIDINE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Universidad Simón BolívarPhase 3
National Cancer Institute, EgyptN/A
Sollis Therapeutics, Inc.Phase 3

See all CLONIDINE clinical trials

Pharmacology for CLONIDINE
Medical Subject Heading (MeSH) Categories for CLONIDINE

US Patents and Regulatory Information for CLONIDINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Rising CLONIDINE HYDROCHLORIDE clonidine hydrochloride TABLET;ORAL 070317-001 Jun 9, 1987 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Actavis Elizabeth CLONIDINE HYDROCHLORIDE clonidine hydrochloride TABLET;ORAL 070975-001 Dec 16, 1986 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Endo Operations CLONIDINE HYDROCHLORIDE clonidine hydrochloride TABLET, EXTENDED RELEASE;ORAL 202983-001 Apr 2, 2014 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Warner Chilcott CLONIDINE HYDROCHLORIDE clonidine hydrochloride TABLET;ORAL 072139-001 Jun 13, 1988 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Aurobindo Pharma Ltd CLONIDINE HYDROCHLORIDE clonidine hydrochloride TABLET;ORAL 070886-002 Aug 31, 1988 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Impax Labs CLONIDINE HYDROCHLORIDE clonidine hydrochloride TABLET;ORAL 078099-003 Aug 27, 2009 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.